Free sign-up Sign in
Free sign-up Sign in
GlobalData

Immuno-Oncology Market

< View all reports

Immuno-Oncology Market Report

Gene Therapy in Oncology

Gene therapies combine reduced treatment duration with a higher chance of success, unlike conventional oncology treatments such as chemotherapy.

This novel approach requires delivery of genetic material to the patient, an uncharted territory in oncology, which will require the implementation of new regulatory guidelines and restructuring of existing treatment algorithms in various oncology indications. Immune-based gene therapy candidates have the potential to succeed in the oncology space, but this uncharted territory will require new regulatory guidelines and restructuring of current treatment algorithms. Our report covers existing competition for gene therapies in oncology, the regulatory framework associated with their clinical development and commercialisation, and the Phase III and Phase II cancer gene therapy candidates set to debut over the next 10 years.

Microbiome
  • Why should you buy this report?
  • Gain an understanding of the trends shaping and driving gene therapy in oncology in the 8MM
  • Analyze various competitor portfolios
  • Identify areas of unmet need within the cancer gene therapy market
  • Get insights to help plan and design your clinical trials
  • Recognize key pricing and reimbursement strategies

What are the gene transfer methods and strategies used in oncology?

GlobalData’s Immuno-oncology market report provides an outline of the current competitive landscape of gene therapies in multiple oncology indications, and covers the late stage clinical development of cancer gene therapies in the 8MM (US, France, Germany, Italy, Spain, UK, Japan and China). The report provides key opinion leader insight on the effect of cancer gene therapies in various treatment paradigms in the oncology space, as well as payer perspective on cost and reimbursement of novel gene therapies.

 

Purchase Today

Single user $ 7,995

Buy Now

reportstore@globaldata.com

+44 (0) 161 359 5813

Not ready to buy yet? Download our free report series guide on Immuno-Oncology

I consent to GlobalData collecting my details provided via this form.

You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our GlobalData Privacy Policy to see how we protect and manage your submitted data.